Evidence map›Paper›PMID 40624988›Full record

ReviewObesity reviews : an official journal of the International Association for the Study of Obesity2025

Delphi Consensus Among French Obesity Experts on Clinical Recommendations for Drug Prescription in Patients With Severe Obesity.

Sarah Berdot, Germain Perrin, Emmanuel Disse, Armelle Arnoux, Eric Bertin, Anne-Laure Borel, Marie-Claude Brindisi, Arnaud De Luca, Edouard-Jules Laforgue, Jean-Daniel Lalau and 8 more

Abstract readReviewConsensus Statement
In one paragraph

Review in Obesity reviews : an official journal of the International Association for the Study of Obesity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Sarah BerdotHeKa Team, Inserm, Paris, France.ORCID https://orcid.org/0000-0001-6607-4318
Germain PerrinHeKa Team, Inserm, Paris, France.
Emmanuel DisseFORCE, French Obesity Research Centre of Excellence/F-CRIN INSERM Network, Paris, France.
Armelle ArnouxHeKa Team, Inserm, Paris, France.
Eric BertinPerformance, Health, Metrology, Society Laboratory (PSMS, EA 7507) of Reims Champagne-Ardenne University and Clinical Nutrition Transversal Unit (UTNC) of Reims University Hospital, Reims, France.
Anne-Laure BorelUniv. Grenoble Alpes, INSERM U1300, Endocrinology Diabetology Nutrition Department, CSO Grenoble Arc Alpin, CHU Grenoble Alpes, Grenoble, France.
Marie-Claude BrindisiEndocrinology-Diabetology-Nutrition Department, Centre Spécialisé de l'Obésité (CSO) Bourgogne, CHU François Mitterrand, Dijon, France.
Arnaud De LucaINSERM UMR 1069, University of Tours; Nutrition and Diabetes, Endocrinology Department, CSO Tours - CHU de Tours, Nantes, France.
Edouard-Jules LaforgueNantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients-Centered Outcomes and HEalth Research, SPHERE, Nantes, France.ORCID https://orcid.org/0000-0002-7400-1212
Jean-Daniel LalauNutrition and Endocrinology Department, CSO Picardie - CHU d'Amiens, Amiens, France.
Yann MatussiereCSO Lyon - Sauvegarde - Clinique de la Sauvegarde, Lyon, France.
Emilie MontastierEndocrinology and Nutrition Department, CIO Occitanie Ouest, CHU Toulouse, Toulouse, France.
Agnès SalléNutrition Department, CSO Anjou Maine (SRAE) - CHU d'Angers, Angers, France.
Bérénice SegrestinCentre de Recherche en Nutrition Humaine Rhône-Alpes, Univ-Lyon, CarMeN Laboratory, INSERM, INRA, INSA Lyon, Université Claude Bernard Lyon 1, Hospices Civils de Lyon, Pierre-Bénite, France.
Valentine SuteauCSO Lyon - Sauvegarde - Clinique de la Sauvegarde, Lyon, France.ORCID https://orcid.org/0000-0002-1316-8190
French Hospital Expert PanelHôpital européen Georges-Pompidou, AP-HP Paris, Paris, France.
Sebastien CzernichowNutrition Department, Hôpital européen Georges-Pompidou, AP-HP Paris, Paris, France.
Brigitte SabatierHeKa Team, Inserm, Paris, France.

Funding

Direction Générale de l'offre de SoinsDirection Générale de l'offre de Soins (Ministry of Health's Research Programme on the performance of the French Healthcare System) PREPS19-0127
6 · The paper itself

Abstract

introductionAlthough the physiologic alterations seen in obesity often affect the pharmacokinetics and pharmacodynamics of drugs, most clinical trials do not consider these aspects specifically for this population. To date, there is no list of potentially inappropriate medications for patients living with obesity. The aim of this study was to use the Delphi method to identify useful recommendations for the prescription of some specific drug classes in patients living with severe obesity.

methodsWe identified five therapeutic groups of drugs using data from the HEGP Clinical Data Warehouse. We conducted a literature review and sought the opinions of local experts to produce potential recommendations. We selected volunteer medical experts from the French network FORCE and set up a two-round Delphi method, concluded by a synthesis meeting, to establish a list of recommendations. In each round, the experts were asked to rate the potential recommendations.

resultsForty-three proposed recommendations were evaluated in the first round. The experts approved four recommendations with a strong consensus and 16 with a relative consensus. In the second round, they approved six recommendations with a strong consensus and 13 with a relative consensus.

conclusionThis is the first study to use the Delphi method to produce a summary of consensus recommendations for several drug classes in patients living with severe obesity. It provides an expert-based consensus on the use of the five most commonly prescribed therapeutic drug classes and develops a list of recommendations for drug prescription in patients living with severe obesity.

Indexed as

Anti-Obesity AgentsDrug PrescriptionsObesity, MorbidDelphi TechniqueFranceHumansPractice Guidelines as TopicAnti-Obesity Agentsbody weight gainclinical recommendationsDelphi methoddrug prescriptionsevere obesity

Identifiers

PMID40624988
PMCPMC12620101

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.